Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06156644
NA
Pulsed-Field-Ablation to Treat Atrial fiBRillation With a novEl multimodalIty Generator
Sponsor: University Hospital Freiburg
View on ClinicalTrials.gov
Summary
In this first-in-human clinical trial a novel generator (INTELLAPULSE), designed and built by Stockert, which supports highly flexible PFA protocols as well as RF interventions will be used. For 12 months and follow-up for 12 months, after a 3-months blanking period 50 consecutive paroxysmal AF patients, eligible for catheter ablation, will be enrolled.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-07-01
Completion Date
2026-12-01
Last Updated
2024-01-03
Healthy Volunteers
No
Conditions
Interventions
DEVICE
PFA
Ablation to treat trail fibrillation